Matthew Pauls, CEO: Savara SVRA Sell · Filed 23/12/29

Trade details

Type: Insider sale
Amount: $395,640
Shares · price: 84,000 sh · $4.71 a share
Held after: 1,302,674 sh
Stock: Savara SVRA
Person: Matthew PaulsCEO
Trade date: 23/12/28
Filed: 23/12/29
Days to filing: 1 days

Sold 6.1% of holdings

Share of holding sold: 6.1%

Savara trades, last 26 weeks

What else happened in Savara around then

Filed or reported within 30 days of the trade day · 23/11/28~24/01/27

Matthew Pauls's recent trades

Matthew PaulsDirector
Sell10b5-1 planPelthos Therapeutics
Sell10b5-1 plan
Pelthos Therapeutics
PTHS
$7,925
371 sh
$7,925
Filed 04/06
Traded 04/02
Matthew PaulsDirector
Sell10b5-1 planPelthos Therapeutics
Sell10b5-1 plan
Pelthos Therapeutics
PTHS
$8,516
415 sh
$8,516
Filed 04/06
Traded 04/02
Matthew PaulsDirector
SellSoleno Therapeutics
Sell
Soleno Therapeutics
SLNO
$424.8K
5,937 sh
$424.8K
Filed 25/03/31
Traded 25/03/28
Matthew PaulsCEO
SellSavara
Sell
Savara
SVRA
$181.1K
54,702 sh
$181.1K
Filed 24/12/16
Traded 24/12/16